CSL HY profit at $US1b-plus for first time
MELBOURNE: Vaccines and blood products supplier CSL’s half-year net profit has surpassed $US1 billion for
MELBOURNE: Vaccines and blood products supplier CSL’s half-year net profit has surpassed $US1 billion for
FEATURED
More are reaching retirement with mortgage as first home buyers get older
Tens of thousands to be recruited into Alzheimer’s trials after landmark drug rejected
Best retirement housing design for Global Awards shortlisted
Retirement apartments to be woven into mixed-use development
Thousands of dementia sufferers are being denied new miracle drug
Property group reveals revised mixed-use housing development plans
INNOVATION
